Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vaccination of children--a systematic review.
Ortqvist Å, Blennow M, Carlsson RM, Hanson LÅ, Lindberg A, Lindqvist L, Magnusson M, Nilsson L, Norlund A, Nyrén O, Olcén P, Olin P, Silfverdal SA, Säwe J, Söderström A, Trollfors B. Ortqvist Å, et al. Among authors: carlsson rm. Acta Paediatr. 2010 Sep;99(461):1-192. doi: 10.1111/j.1651-2227.2010.01823.x. Acta Paediatr. 2010. PMID: 20712829 Review. No abstract available.
Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine.
Carlsson RM, Claesson BA, Käyhty H, Selstam U, Iwarson S. Carlsson RM, et al. Vaccine. 1999 Oct 14;18(5-6):468-78. doi: 10.1016/s0264-410x(99)00238-8. Vaccine. 1999. PMID: 10519936 Clinical Trial.
Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age.
Carlsson RM, Claesson BA, Selstam U, Fagerlund E, Granström M, Blondeau C, Hoffenbach A. Carlsson RM, et al. Pediatr Infect Dis J. 1998 Nov;17(11):1026-33. doi: 10.1097/00006454-199811000-00013. Pediatr Infect Dis J. 1998. PMID: 9849987 Clinical Trial.
Serum antibodies against haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination.
Carlsson RM, Claesson BA, Lagergård T, Käyhty H. Carlsson RM, et al. Scand J Infect Dis. 1996;28(5):519-23. doi: 10.3109/00365549609037951. Scand J Infect Dis. 1996. PMID: 8953685
Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.
Carlsson RM, Claesson BA, Iwarson S, Lagergård T, Käyhty H. Carlsson RM, et al. Pediatr Infect Dis J. 1994 Jan;13(1):27-33. doi: 10.1097/00006454-199401000-00007. Pediatr Infect Dis J. 1994. PMID: 8170729 Clinical Trial.
Dose response study of an inactivated hepatitis A virus vaccine.
Carlsson RM, Claesson BA, Iwarson SA. Carlsson RM, et al. J Hepatol. 1993;18 Suppl 2:S41-5. doi: 10.1016/s0168-8278(05)80377-0. J Hepatol. 1993. PMID: 8182272 Clinical Trial.
Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 years.
Carlsson RM, Gustafsson L, Hallander HO, Ljungman M, Olin P, Gothefors L, Nilsson L, Netterlid E. Carlsson RM, et al. Vaccine. 2015 Jul 17;33(31):3717-25. doi: 10.1016/j.vaccine.2015.05.079. Epub 2015 Jun 7. Vaccine. 2015. PMID: 26057135 Clinical Trial.
Surveillance of infant pertussis in Sweden 1998-2012; severity of disease in relation to the national vaccination programme.
Carlsson RM, von Segebaden K, Bergstrom J, Kling AM, Nilsson L. Carlsson RM, et al. Euro Surveill. 2015 Feb 12;20(6):21032. doi: 10.2807/1560-7917.es2015.20.6.21032. Euro Surveill. 2015. PMID: 25695476 Free article. Clinical Trial.
Modeling the waning and boosting of immunity from infection or vaccination.
Carlsson RM, Childs LM, Feng Z, Glasser JW, Heffernan JM, Li J, Röst G. Carlsson RM, et al. J Theor Biol. 2020 Jul 21;497:110265. doi: 10.1016/j.jtbi.2020.110265. Epub 2020 Apr 6. J Theor Biol. 2020. PMID: 32272134 Free article.
28 results
Jump to page
Feedback